Michael Paul Stany MD

Obstetrics & Gynecology•Nashville, TN

Gynecologic Oncology

Associate Professor, University of Tennessee Health Sciences

Join to View Full Profile

2004 Hayes StreetSte 205Nashville, TN 37203
Phone+1 615-284-4646
Fax+1 615-284-4674

Education & Training

National Capital ConsortiumResidency, Obstetrics and Gynecology, 2002 - 2006
University of Kentucky College of MedicineClass of 2002

Certifications & Licensure

TN State Medical License 2014 - 2026
KY State Medical License 2016 - 2025
MD State Medical License 2009 - 2015
MI State Medical License 2011 - 2015
SD State Medical License 1900 - 2015
DC State Medical License 2009 - 2014
GA State Medical License 2013 - 2014
VA State Medical License 2003 - 2014
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Join now to see all

Clinical Trials

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
ACTIVE_NOT_RECRUITING
PHASE3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Start of enrollment: 2014 Feb 27
ACTIVE_NOT_RECRUITING
PHASE2, PHASE3
Join now to see all

Publications & Presentations

PubMed

2 citations
Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis.
Shalini Chhabra, Pooja Sangani, Reagan Saig, Michael Stany
Gynecologic Oncology Reports. 2022-02-01
Dedifferentiated endometrioid adenocarcinoma with trophoblastic components: Prolonged remission after treatment with bleomycin, etoposide, and cisplatin
Alexa K. Martin, Elizabeth G. Jackson, Henry D. Edwards, Michael P. Stany
Gynecologic Oncology Reports. 2020-03-18
42 citations
Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer.
Stephen Shuford, Christine Wilhelm, Melissa Rayner, Ashley Elrod, Melissa Millard
Scientific Reports. 2019-08-01

Other

Laparoscopic surgery in pregnancy
Stany MP, Elkas JC
http://www.uptodate.com/contents/laparoscopic-surgery-in-pregnancy
UpToDate, Wolters Kluwer Health - 2012-04-23

Press Mentions

OneOncology Partner Practices Add Local Physician Practices and Expand Sites of CareNovember 13th, 2024
OneOncology Partner Practices Add Local Physician Practices and Expand Sites of CareNovember 13th, 2024
3-Time Cancer Survivor Sheds Light on Ovarian Cancer Awareness MonthSeptember 24th, 2021
Join now to see all